Literature DB >> 30023104

Stereotactic body radiotherapy for early-stage non-small cell lung cancer has low post-treatment mortality.

Joshua R Niska1, Terence T Sio1, Thomas B Daniels1, Staci E Beamer2, Dawn E Jaroszewski2, Helen J Ross3, Harshita R Paripati3, Steven E Schild1.   

Abstract

Entities:  

Year:  2018        PMID： 30023104      PMCID： PMC6036010          DOI： 10.21037/jtd.2018.04.169

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.

Authors:  Patrick M Forde; Jamie E Chaft; Kellie N Smith; Valsamo Anagnostou; Tricia R Cottrell; Matthew D Hellmann; Marianna Zahurak; Stephen C Yang; David R Jones; Stephen Broderick; Richard J Battafarano; Moises J Velez; Natasha Rekhtman; Zachary Olah; Jarushka Naidoo; Kristen A Marrone; Franco Verde; Haidan Guo; Jiajia Zhang; Justina X Caushi; Hok Yee Chan; John-William Sidhom; Robert B Scharpf; James White; Edward Gabrielson; Hao Wang; Gary L Rosner; Valerie Rusch; Jedd D Wolchok; Taha Merghoub; Janis M Taube; Victor E Velculescu; Suzanne L Topalian; Julie R Brahmer; Drew M Pardoll
Journal:  N Engl J Med       Date:  2018-04-16       Impact factor: 91.245

2.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

3.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

4.  Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503.

Authors:  Leslie J Kohman; Lin Gu; Nasser Altorki; Ernest Scalzetti; Linda J Veit; Jason M Wallen; Xiaofei Wang
Journal:  J Thorac Cardiovasc Surg       Date:  2017-02-07       Impact factor: 5.209

5.  Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Authors:  Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth
Journal:  Lancet Oncol       Date:  2015-05-13       Impact factor: 41.316

6.  Stage I Lung SBRT Clinical Practice Patterns.

Authors:  Christopher D Corso; Henry S Park; Amy C Moreno; Anthony W Kim; James B Yu; Zain A Husain; Roy H Decker
Journal:  Am J Clin Oncol       Date:  2017-08       Impact factor: 2.339

7.  Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.

Authors:  Melanie Subramanian; Timothy McMurry; Bryan F Meyers; Varun Puri; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2018-03-23       Impact factor: 4.330

8.  Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.

Authors:  Ken Kodama; Masahiko Higashiyama; Jiro Okami; Toshiteru Tokunaga; Fumio Imamura; Tomio Nakayama; Atsuo Inoue; Keiko Kuriyama
Journal:  Ann Thorac Surg       Date:  2015-11-03       Impact factor: 4.330

9.  Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial.

Authors:  Fan Yang; Xizhao Sui; Xiuyuan Chen; Lixue Zhang; Xun Wang; Shaodong Wang; Jun Wang
Journal:  Trials       Date:  2016-04-07       Impact factor: 2.279

10.  The National Cancer Data Base: a powerful initiative to improve cancer care in the United States.

Authors:  Karl Y Bilimoria; Andrew K Stewart; David P Winchester; Clifford Y Ko
Journal:  Ann Surg Oncol       Date:  2008-01-09       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.